A table showing common adverse events occurring in ≥5% of patients taking Mounjaro 15 mg or maximum tolerated dose plus metformin (n=397) or intensified conventional care plus metformin (n=395). For Mounjaro 15 mg or MTD plus metformin and ICC plus metformin, respectively: nausea 22.7% and 17.5%; diarrhea 21.9% and 13.4%; dyspepsia 17.1% and 6.3%; constipation 14.4% and 11.6%; vomiting 13.9% and 10.4%; eructation 6.8% and 1.5%; decreased appetite 5.5% and 3.5%; headache 5.5% and 3.0%; influenza 4.5% and 5.8% and nasopharyngitis 2.5% and 5.3%.